Merck Germany Lands Bio-Techne In $11.3 Billion Cash Deal
Germany's Merck Is Buying Bio-Techne for $11.3 Billion
Germany's Merck to buy Bio-Techne for $73 per share
Germany's Merck to Buy Bio-Techne for $11 Billion
TrumpRx lists many medicines at prices higher than paid in UK
Sanofi Names Merck KGaA's Garijo to Replace Hudson as CEO
Halozyme Granted Injunction Against Merck & Co. in Germany in Keytruda Patent Case
Trump rolls out his latest deal with a drugmaker. This one stems from his campaign promise to cover all IVF costs.
Trump announces efforts to expand access to IVF drugs
Germany's Merck Sets Out Midterm Sales Growth, Profitability Expansion Targets
Germany's Merck tweaks mid-term healthcare unit guidance
Chinese police investigating app fraud case, says German drugmaker Merck KGaA
Germany's Merck drops China surcharge on orders after US-China tariff deal
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
Germany's Merck KGaA in $3.9 bln deal to acquire US biotech firm SpringWorks
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Exclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Merck KGaA says high asset prices call for prudent M&A approach